MedTrace Logo

Effects of Tremella Fuciformis on Improvement in Cognitive-Bio-Markers of Cognitive Functions

NCT02377024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2015-07-01

No results posted yet for this study

Summary

The objective of this study is to demonstrate the cognitive enhancement effect and safety of Tremella Fuciformis, using the cognitive and clinical indicators (e.g. memory, attention, and psychomotor speed) and the latest brain imaging methods for healthy adults suffering subjective cognitive impairment.

Conditions

  • Healthy Adults With Subjective Memory Complaints

Interventions

DIETARY_SUPPLEMENT

TF 600mg

DIETARY_SUPPLEMENT

TF 1200mg

DIETARY_SUPPLEMENT

placebo

Sponsors & Collaborators

  • Ewha Womans University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377024 on ClinicalTrials.gov